Literature DB >> 24975023

Effect of GABRA2 genotype on development of incentive-motivation circuitry in a sample enriched for alcoholism risk.

Mary M Heitzeg1, Sandra Villafuerte2, Barbara J Weiland3, Mary-Anne Enoch4, Margit Burmeister5, Jon-Kar Zubieta2, Robert A Zucker1.   

Abstract

Heightened reactivity of the incentive-motivation system has been proposed to underlie adolescent-typical risky behaviors, including problem alcohol involvement. However, even in adolescence considerable individual variation in these behaviors exists, which may have genetic underpinnings and be related to variations in risk for later alcohol use disorder (AUD). Variants in GABRA2 have been associated with adult alcohol dependence as well as phenotypic precursors, including impulsiveness and externalizing behaviors. We investigated the impact of GABRA2 on the developmental trajectory of nucleus accumbens (NAcc) activation during anticipation of monetary reward from childhood to young adulthood. Functional MRI during a monetary incentive delay task was collected in 175 participants, with the majority (n = 151) undergoing repeated scanning at 1- to 2-year intervals. One group entered the study at age 8-13 years (n = 76) and another entered at age 18-23 years (n = 99). Most participants were children of alcoholics (79%) and thus at heightened risk for AUD. A total of 473 sessions were completed, covering ages 8-27 years. NAcc activation was heightened during adolescence compared with childhood and young adulthood. GABRA2 genotype (SNP rs279858) was associated with individual differences in NAcc activation specifically during adolescence, with the minor allele (G) associated with greater activation. Furthermore, NAcc activation mediated an effect of genotype on alcohol problems (n = 104). This work demonstrates an impact of GABRA2 genotype on incentive-motivation neurocircuitry in adolescence, with implications for vulnerability to alcoholism. These findings represent an important step toward understanding the genetic and neural basis of individual differences in how risk for addiction unfolds across development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24975023      PMCID: PMC4229579          DOI: 10.1038/npp.2014.161

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Neural response to reward anticipation is modulated by Gray's impulsivity.

Authors:  Tim Hahn; Thomas Dresler; Ann-Christine Ehlis; Michael M Plichta; Sebastian Heinzel; Thomas Polak; Klaus-Peter Lesch; Felix Breuer; Peter M Jakob; Andreas J Fallgatter
Journal:  Neuroimage       Date:  2009-03-25       Impact factor: 6.556

3.  Addictions biology: haplotype-based analysis for 130 candidate genes on a single array.

Authors:  Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman
Journal:  Alcohol Alcohol       Date:  2008-05-12       Impact factor: 2.826

Review 4.  The mysterious motivational functions of mesolimbic dopamine.

Authors:  John D Salamone; Mercè Correa
Journal:  Neuron       Date:  2012-11-08       Impact factor: 17.173

5.  Different developmental trajectories for anticipation and receipt of reward during adolescence.

Authors:  Janna Marie Hoogendam; René S Kahn; Manon H J Hillegers; Mariët van Buuren; Matthijs Vink
Journal:  Dev Cogn Neurosci       Date:  2013-09-03       Impact factor: 6.464

Review 6.  Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.

Authors:  W J McBride; T K Li
Journal:  Crit Rev Neurobiol       Date:  1998

Review 7.  Methodological approaches in developmental neuroimaging studies.

Authors:  Beatriz Luna; Katerina Velanova; Charles F Geier
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

8.  Neuroplasticity in the mesolimbic system induced by natural reward and subsequent reward abstinence.

Authors:  Kyle K Pitchers; Margaret E Balfour; Michael N Lehman; Neil M Richtand; Lei Yu; Lique M Coolen
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

9.  Allelic and haplotypic association of GABRA2 with alcohol dependence.

Authors:  Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

10.  Electrophysiological characterization of GABAergic neurons in the ventral tegmental area.

Authors:  S C Steffensen; A L Svingos; V M Pickel; S J Henriksen
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more
  37 in total

1.  Reward-Related Brain Activity Prospectively Predicts Increases in Alcohol Use in Adolescents.

Authors:  Johnna R Swartz; David G Weissman; Emilio Ferrer; Sarah J Beard; Catherine Fassbender; Richard W Robins; Paul D Hastings; Amanda E Guyer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-06-04       Impact factor: 8.829

Review 2.  Developmental Cognitive Neuroscience of Adolescent Sexual Risk and Alcohol Use.

Authors:  Sarah W Feldstein Ewing; Sephira G Ryman; Arielle S Gillman; Barbara J Weiland; Rachel E Thayer; Angela D Bryan
Journal:  AIDS Behav       Date:  2016-01

3.  Beyond risk: Prospective effects of GABA Receptor Subunit Alpha-2 (GABRA2) × Positive Peer Involvement on adolescent behavior.

Authors:  Elisa M Trucco; Sandra Villafuerte; Margit Burmeister; Robert A Zucker
Journal:  Dev Psychopathol       Date:  2016-06-17

Review 4.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

5.  Reward-related ventral striatum activity links polygenic risk for attention-deficit/hyperactivity disorder to problematic alcohol use in young adulthood.

Authors:  Caitlin E Carey; Annchen R Knodt; Emily Drabant Conley; Ahmad R Hariri; Ryan Bogdan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

6.  Alcohol Use Disorder, But Not Cannabis Use Disorder, Symptomatology in Adolescents Is Associated With Reduced Differential Responsiveness to Reward Versus Punishment Feedback During Instrumental Learning.

Authors:  Joseph Aloi; Karina S Blair; Kathleen I Crum; Johannah Bashford-Largo; Ru Zhang; Jennie Lukoff; Erin Carollo; Stuart F White; Soonjo Hwang; Francesca M Filbey; Matthew Dobbertin; R James R Blair
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-02-19

Review 7.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

8.  GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures.

Authors:  Richard Lieberman; Henry R Kranzler; Pujan Joshi; Dong-Guk Shin; Jonathan Covault
Journal:  Alcohol Clin Exp Res       Date:  2015-08-06       Impact factor: 3.455

9.  Striatal dopaminergic reward response relates to age of first drunkenness and feedback response in at-risk youth.

Authors:  Barbara J Weiland; Robert A Zucker; Jon-Kar Zubieta; Mary M Heitzeg
Journal:  Addict Biol       Date:  2016-01-05       Impact factor: 4.280

10.  A Prospective Cohort Study of Influences on Externalizing Behaviors Across Childhood: Results From a Nurse Home Visiting Randomized Controlled Trial.

Authors:  Mary-Anne Enoch; Harriet Kitzman; Joyce A Smith; Elizabeth Anson; Colin A Hodgkinson; David Goldman; David L Olds
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-03-02       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.